Therapy News and Research

RSS

HU researchers develop new biological drug that may cure acute myeloid leukemia

Acute myeloid leukemia is one of the most aggressive cancers. While other cancers have benefited from new treatments, there has been no encouraging news for most leukemia patients for the past 40 years. Until now.

24 Aug 2018

Researchers find new therapy to prevent drug resistance for melanoma patients

Mount Sinai researchers have discovered a previously unknown reason for drug resistance in a common subtype of melanoma, one of the deadliest forms of cancer, and in turn, have found a new therapy that could prevent or reverse drug resistance for melanoma patients with a particular gene mutation, according to a study published in Nature Communications in August.

24 Aug 2018

Researchers take major step in eliminating cancer without harming healthy tissue

A major advance towards targeting cancer without harming healthy tissue has been discovered by University of Bristol researchers.

24 Aug 2018

New treatment destroys part of tumor and attacks persistent surviving cancer cells

Scientists at the VIB-UGent Center for Medical Biotechnology have taken important steps forward in the development of a cancer-targeting immunotherapy.

24 Aug 2018

FDA grants Breakthrough designation to Dthera Sciences' development-stage product for Alzheimer's

Dthera™ Sciences, the leading digital therapeutic company focusing on the elderly and individuals with neurodegenerative diseases, announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device designation to the Company's development-stage product, DTHR-ALZ.

24 Aug 2018

MDA announces 34 new grants totaling $9.9 million to accelerate neuromuscular research

The Muscular Dystrophy Association today announced the award of 34 new grants totaling more than $9.9 million for its summer round of funding. These new grants represent a continued commitment by MDA to fund groundbreaking research that will accelerate treatments and cures for the more than 40 diseases in its program.

24 Aug 2018

Far-UVC light could help prevent catheter-based and driveline infections

A specific wavelength of ultraviolet light, now delivered through light-diffusing optical fibers, is highly effective at killing drug-resistant bacteria in cell cultures, according to a new study led by David J. Brenner, PhD, a professor of radiation biophysics at Columbia University Vagelos College of Physicians and Surgeons.

24 Aug 2018

Finding ways to improve cell replacement therapy for Parkinson's disease

Parkinson's disease is a neurodegenerative disease that affects dopamine signaling neurons in patients' brains. Cell-replacement therapy shows some promise as a treatment for Parkinson's. A recent paper in the journal Molecular & Cellular Proteomics reports a technical advance in selecting cells to use in this therapy.

24 Aug 2018

'Plastic antibodies' effectively target and eliminate tumor cells

A joint research team from Russia and the U.K. has demonstrated the possibility of developing a new type of anti-neoplastic drugs based on nanoMIPs, or "plastic antibodies." NanoMIPs are synthetic polymers that can function as antibodies, selectively binding to target proteins on the surface of cancer cells.

23 Aug 2018

GW researchers to develop model for studying role of COMPASS protein in pancreatic cancer

Pancreatic cancer is the fourth most common cause of cancer related deaths in the United States with a five-year survival rate of less than 10 percent. Although it is defined by a small number of genetic alterations, efforts to pharmacologically target specific pathways have been unsuccessful.

23 Aug 2018

Scientists identify novel biomarkers that indicate risk of polyneuropathy

Polyneuropathy is one of the most common complications in people with diabetes. However, it can also occur with certain risk factors or diseases before the onset of diabetes.

23 Aug 2018

Bluebird bio collaborates with Gritstone Oncology to develop novel cancer cell therapies

Bluebird bio, Inc. and Gritstone Oncology, Inc. today announced a collaboration to research, develop and commercialize products for the treatment of cancer using cell therapy.

23 Aug 2018

Study finds new way to target escalating rates of obesity

A novel drug is being touted as a major step forward in the battle against Australia’s escalating rates of obesity and associated metabolic diseases.

23 Aug 2018

Pediatric antibiotic prescriptions lead to nearly 70,000 ER visits in the U.S. each year

The use of antibiotics drives the development of antibiotic resistance, a major threat to public health worldwide. But these drugs also carry the risk of harm to individual patients, including children.

23 Aug 2018

Eisai: EC approves marketing of LENVIMA as first-line treatment for hepatocellular carcinoma

Eisai Co., Ltd. and Merck & Co., Inc., Kenilworth N.J., U.S.A., known as MSD outside of the United States and Canada, announced today that the European Commission has granted a marketing authorization for the oral receptor tyrosine kinase inhibitor LENVIMA (lenvatinib mesylate) as a single agent for the first-line treatment of adult patients with advanced or unresectable hepatocellular carcinoma who have received no prior systemic therapy.

23 Aug 2018

Scientists work towards solving mystery of incurable blood diseases

Scientists may be on the road to solving the mystery of a group of mostly incurable blood diseases called myelodysplastic syndromes, which cause people to have immature, malfunctioning bone marrow cells that fuel a diverse set of health problems and can lead to leukemia.

23 Aug 2018

Electrical stimulation of the brain may help treat symptoms of neurodegenerative ataxias

Electrical stimulation of the brain and spinal cord may help treat the symptoms of rare movement disorders called neurodegenerative ataxias, according to a study published in the August 22, 2018, online issue of Neurology, the medical journal of the American Academy of Neurology.

23 Aug 2018

Penn's Radiation Oncology department provides VR mindfulness experience for patients

As your eyes scan the horizon, the starry nightscape gives way to the first hints of light as the sun peeks above the point where the ocean meets the sky. As the sun rises over the water, you glance to your right and notice a swing hanging from a tree that's lightly rocking in the gentle breeze, a breeze you can hear as it rustles leaves and calmly plays through the wind chimes on the deck of the house nearby.

22 Aug 2018

Advanced sequencing of nasal polyps provides new insights into allergic conditions

Nasal polyps - soft, grape-like outgrowths that can appear in the nasal passages and sinuses - can be chronic and relentless. Although noncancerous, these outgrowths can grow large enough to block the nose and sinuses, leading to discomfort, breathing problems and infections.

22 Aug 2018

Genetic variants impact outcome in dilated cardiomyopathy patients of African ancestry

Genetic testing is a powerful diagnostic tool that is increasingly being used for the diagnosis of dilated cardiomyopathy, a disease in which the heart becomes enlarged, making it difficult to pump blood. Cardiomyopathy affects more than 3.5 million people in the United States.

22 Aug 2018

Therapy News and Research

HU researchers develop new biological drug that may cure acute myeloid leukemia

Researchers find new therapy to prevent drug resistance for melanoma patients

Researchers take major step in eliminating cancer without harming healthy tissue

New treatment destroys part of tumor and attacks persistent surviving cancer cells

FDA grants Breakthrough designation to Dthera Sciences' development-stage product for Alzheimer's

MDA announces 34 new grants totaling $9.9 million to accelerate neuromuscular research

Far-UVC light could help prevent catheter-based and driveline infections

Finding ways to improve cell replacement therapy for Parkinson's disease

'Plastic antibodies' effectively target and eliminate tumor cells

GW researchers to develop model for studying role of COMPASS protein in pancreatic cancer

Scientists identify novel biomarkers that indicate risk of polyneuropathy

Bluebird bio collaborates with Gritstone Oncology to develop novel cancer cell therapies

Study finds new way to target escalating rates of obesity

Pediatric antibiotic prescriptions lead to nearly 70,000 ER visits in the U.S. each year

Eisai: EC approves marketing of LENVIMA as first-line treatment for hepatocellular carcinoma

Scientists work towards solving mystery of incurable blood diseases

Electrical stimulation of the brain may help treat symptoms of neurodegenerative ataxias

Penn's Radiation Oncology department provides VR mindfulness experience for patients

Advanced sequencing of nasal polyps provides new insights into allergic conditions

Genetic variants impact outcome in dilated cardiomyopathy patients of African ancestry

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News